{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:27:29Z","timestamp":1773343649163,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jmgm.2025.109079","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T15:49:29Z","timestamp":1747151369000},"page":"109079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In silico screening of peptide inhibitors targeting \u03b1-synuclein for Parkinson's disease"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4469-9709","authenticated-orcid":false,"given":"Gulsah","family":"Gul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2025.109079_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of Parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109079_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jmgm.2025.109079_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/bmj.39289.437454.AD","article-title":"Parkinson's disease","volume":"335","author":"Clarke","year":"2007","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jmgm.2025.109079_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-017-0099-z","article-title":"Current understanding of the molecular mechanisms in Parkinson's disease: targets for potential treatments","volume":"6","author":"Maiti","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.jmgm.2025.109079_bib5","first-page":"170","volume":"vol. 19","author":"Blauwendraat","year":"2022"},{"key":"10.1016\/j.jmgm.2025.109079_bib6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.jmgm.2025.109079_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2016.00408","article-title":"Alpha-synuclein oligomers-neurotoxic molecules in Parkinson's disease and other lewy body disorders","volume":"10","author":"Ingelsson","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109079_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jmgm.2025.109079_bib9","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1007\/PL00000671","article-title":"Alpha-synuclein and Parkinson's disease","volume":"57","author":"L\u00fccking","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmgm.2025.109079_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jmgm.2025.109079_bib11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1021\/ar050073t","article-title":"The aggregation and fibrillation of \u03b1-synuclein","volume":"39","author":"Fink","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jmgm.2025.109079_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00368-6","article-title":"Initiation and propagation of \u03b1-synuclein aggregation in the nervous system","volume":"15","author":"Hijaz","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jmgm.2025.109079_bib13","article-title":"Implementing complementary approaches to shape the mechanism of \u03b1-synuclein oligomerization as a model of amyloid aggregation","volume":"27","author":"Giamp\u00e0","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109079_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4827","article-title":"Direct observation of the three regions in \u03b1-synuclein that determine its membrane-bound behaviour","volume":"5","author":"Fusco","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2025.109079_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183536","article-title":"Interactions of \u03b1-synuclein oligomers with lipid membranes","volume":"1863","author":"Musteikyt\u0117","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jmgm.2025.109079_bib16","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1021\/acs.jpcb.1c01281","article-title":"Membrane interactions of \u03b1-synuclein revealed by multiscale molecular dynamics simulations, markov state models, and NMR","volume":"125","author":"Amos","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2025.109079_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","article-title":"Therapeutic approaches to target a-syn pathology","volume":"298","author":"Brundina","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jmgm.2025.109079_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-synuclein as a therapy for Parkinson's disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109079_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107547","article-title":"Identification of potential natural neuroprotective molecules for Parkinson's disease by using chemoinformatics and molecular docking","volume":"97","author":"Rond\u00f3n-Villarreal","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2025.109079_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.108010","article-title":"Identification of new alpha-synuclein fibrillogenesis inhibitor using in silico structure-based virtual screening","volume":"108","author":"Sahihi","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2025.109079_bib21","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.32604\/biocell.2022.021224","article-title":"Pharmacotherapeutics and molecular docking studies of alpha-synuclein modulators as promising therapeutics for Parkinson's disease","volume":"46","author":"Ali","year":"2022","journal-title":"Biocell"},{"key":"10.1016\/j.jmgm.2025.109079_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27092834","article-title":"In silico molecular docking analysis of karanjin against alzheimer's and Parkinson's diseases as a potential natural lead molecule for new drug design, development and therapy","volume":"27","author":"Gnanaraj","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2025.109079_bib23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jmgm.2025.109079_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/biom14030264","article-title":"Exploring FDA-approved frontiers: insights into natural and engineered peptide analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and \u03b1-MSH realms","volume":"14","author":"Al Musaimi","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmgm.2025.109079_bib25","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1096\/fj.03-1346fje","article-title":"A strategy for designing inhibitors of \u03b1 \u2010synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders","volume":"18","author":"El-Agnaf","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jmgm.2025.109079_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-8-451","article-title":"Peptide ligand screening of \u03b1-synuclein aggregation modulators by in silico panning","volume":"8","author":"Abe","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.jmgm.2025.109079_bib27","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1074\/jbc.M114.620484","article-title":"Intracellular screening of a peptide library to derive a potent peptide inhibitor of \u03b1-synuclein aggregation","volume":"290","author":"Cheruvara","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2025.109079_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnmol.2021.659926","article-title":"Identification of two novel peptides that inhibit \u03b1-synuclein toxicity and aggregation","volume":"14","author":"Popova","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jmgm.2025.109079_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/database\/baad084","article-title":"aSynPEP-DB: a database of biogenic peptides for inhibiting \u03b1-synuclein aggregation","volume":"2023","author":"Pintado-Grima","year":"2023","journal-title":"Database"},{"key":"10.1016\/j.jmgm.2025.109079_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wnan.1695","article-title":"Brain penetrating peptides and peptide\u2013drug conjugates to overcome the blood\u2013brain barrier and target CNS diseases","volume":"13","author":"Zhou","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.jmgm.2025.109079_bib31","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.jmgm.2025.109079_bib32","first-page":"1","article-title":"BBPpredict: a web service for identifying blood-brain barrier penetrating peptides","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.jmgm.2025.109079_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/acs.jcim.0c01115","article-title":"BBPpred: sequence-based prediction of blood-brain barrier peptides with feature representation learning and logistic regression","volume":"61","author":"Dai","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109079_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081237","article-title":"B3pred: a random-forest-based method for predicting and designing blood\u2013brain barrier penetrating peptides","volume":"13","author":"Kumar","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmgm.2025.109079_bib35","series-title":"CPP, Cell-Penetrating Peptides","author":"Langel","year":"2019"},{"key":"10.1016\/j.jmgm.2025.109079_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-022-03059-8","article-title":"The C-terminal tail of \u03b1-synuclein protects against aggregate replication but is critical for oligomerization","volume":"5","author":"Farzadfard","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jmgm.2025.109079_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbapap.2022.140826","article-title":"Designer D-peptides targeting the N-terminal region of \u03b1-synuclein to prevent parkinsonian-associated fibrilization and cytotoxicity","volume":"1870","author":"Horsley","year":"2022","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.jmgm.2025.109079_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167323","article-title":"A downsized and optimised intracellular library-derived peptide prevents alpha-synuclein primary nucleation and toxicity without impacting upon lipid binding","volume":"433","author":"Meade","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2025.109079_bib39","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109079_bib40","first-page":"1","article-title":"Peptidebuilder: a simple python library to generate model peptides","volume":"2013","author":"Tien","year":"2013","journal-title":"PeerJ"},{"key":"10.1016\/j.jmgm.2025.109079_bib41","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1093\/bioinformatics\/btz459","article-title":"AutoDock CrankPep: combining folding and docking to predict protein-peptide complexes","volume":"35","author":"Zhang","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2025.109079_bib42","series-title":"The Python Library Reference","author":"Van Rossum","year":"2020"},{"key":"10.1016\/j.jmgm.2025.109079_bib43","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/bioinformatics\/bty140","article-title":"IFeature: a Python package and web server for features extraction and selection from protein and peptide sequences","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmgm.2025.109079_bib44","series-title":"GROMACS 2021.3 Source Code, 2021.3","author":"Lindahl","year":"2021"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109079_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jmgm.2025.109079_bib46","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2025.109079_bib47","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2025.109079_bib48","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"13","key":"10.1016\/j.jmgm.2025.109079_bib49","doi-asserted-by":"crossref","DOI":"10.1063\/1.2013227","article-title":"A configurational temperature Nos\u00e9-Hoover thermostat","volume":"123","author":"Braga","year":"2005","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2025.109079_bib50","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.jmgm.2025.109079_bib51","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"Gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2025.109079_bib52","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/nar\/gkh429","article-title":"STRIDE: a web server for secondary structure assignment from known atomic coordinates of proteins","volume":"32","author":"Heinig","year":"2004","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325001391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325001391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:18:53Z","timestamp":1748434733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":52,"alternative-id":["S1093326325001391"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109079","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico screening of peptide inhibitors targeting \u03b1-synuclein for Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109079"}}